NCT07915440 Application of Meaning-Based Psychotherapy to a Sample of Patients With Chronic Pain
| NCT ID | NCT07915440 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Clinico Universitario San Cecilio |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 118 participants |
| Start Date | 2025-07-10 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 118 participants in total. It began in 2025-07-10 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aimes of this study is to determine whether Meaning-Based Psychotherapy (MBP) is an effective therapy for improving sense of purpose, reducing depression, and improving quality of life in people with chronic pain and to verify the effectiveness of the MBP intervention for participants in a randomized controlled trial (RCT) by comparing it with the optimized usual care (Cognitive-behavioural Psychotherapy por chronic pain).
Eligibility Criteria
Inclusion Criteria: 1. Participants will be adults; 2. Patients treated at Mental Health Service for anxiety and depressive symptoms related to chronic non-cancer pain; the diagnosis will be recorded according to the ICD-10 criteria identified in their medical records. 3. Tendency to catastrophize pain (score greater than 30 on the Pain Catastrophizing Questionnaire (García-Campayo, J., 2008)); 4. Low sense of purpose or lack of a defined sense of purpose in life (score less than 105 on the Purpose in Life Test (PIL) (Crumbaugh \& Maholick, 1969). Exclusion Criteria: 1. Diagnoses of a severe mental disorder (schizophrenia, substance dependence, dementia, or cognitive impairment) identified through information obtained in a clinical interview or digital health record. 2. Severe suicidal ideation or a suicide attempt within the last 6 months. This will be assessed using responses to item 9 of the Beck Depression Inventory (2nd ed.). This item is commonly used in clinical studies to identify suicidal ideation and has proven to be a good predictor of suicidal intent and risk (Green et al. 2015, von Brachel et al. 2018). Participants with recent suicide attempts or whose response to item 3 ("I would commit suicide if I had the opportunity") will be excluded, as this indicates suicidal intent and a higher risk of suicide (Green et al. 2015). In such cases, referral to the appropriate mental health service will be prioritized according to protocol.
Contact & Investigator
Heliodoro Marco Salvador, Ph.D
STUDY DIRECTOR
University of Valencia
Frequently Asked Questions
Who can join the NCT07915440 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07915440 currently recruiting?
Yes, NCT07915440 is actively recruiting participants. Contact the research team at leire.hidalgo.sspa@juntadeandalucia.es for enrollment information.
Where is the NCT07915440 trial being conducted?
This trial is being conducted at Granada, Spain.
Who is sponsoring the NCT07915440 clinical trial?
NCT07915440 is sponsored by Hospital Clinico Universitario San Cecilio. The principal investigator is Heliodoro Marco Salvador, Ph.D at University of Valencia. The trial plans to enroll 118 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.